期刊文献+

法尼醇X受体及其激动剂与肝脏疾病 被引量:2

下载PDF
导出
摘要 法尼醇X受体(farnesoid X receptor,FXR)又名胆汁酸受体,是一种配体激活转录因子。FXR激动剂作用于FXR后,激活一系列复杂的下游通路,其代谢产物参与调节胆汁酸、糖类、脂质的稳态,进而在肝脏组织炎症、纤维化、再生及癌变过程中起到重要的调节作用,影响肝脏代谢性疾病的发生发展。寻找治疗靶点更精确且高效低毒的FXR激动剂,治疗肝脏代谢性疾病是当前的研究热点。本文将主要围绕FXR对代谢的调节及其与肝脏疾病的关系及其激动剂的研究进展进行讨论。
出处 《肝脏》 2021年第11期1293-1297,共5页 Chinese Hepatology
  • 相关文献

参考文献5

二级参考文献56

  • 1张亚飞,聂青和,徐辉,谢玉梅,邵彬.以TIMP-2为靶基因的反义寡核苷酸对肝纤维化大鼠肝功能生化和肝纤维化指标的影响[J].肝脏,2005,10(4):291-293. 被引量:1
  • 2胡中伟,郭家伟,邓西龙.非酒精性脂肪肝与血清瘦素和胰岛素抵抗关系[J].南方医科大学学报,2006,26(6):853-855. 被引量:10
  • 3陈超丽,甄真,刘晓平,冯翠玲,张新元.慢性乙型肝炎肝组织中MMP-2、TIMP-1与肝纤维化关系的研究[J].临床肝胆病杂志,2006,22(6):419-421. 被引量:1
  • 4Urtasun R, Lopategi A, George J, et al. Osteopontin an oxi- dant stress sensitive cytokine, up -regulates collagen -I via integrin e(V) 13(3 ) engagement and PI3K/pAkt/NFKB signa- ling[J]. Hepatology, 2012, 55(2): 594 -608.
  • 5Yang J, Zheng J, Wu L, et al. NDRG2 ameliorates hepatic fibrosis by inhibiting the TGF -l/Smad pathway and altering the MMP2/TIMP2 ratio in rats[J]. PLoS One, 2011, 6 (11): e27710.
  • 6Fiorucci S, Rizzo G, Antonelli E, et al. Cross -talk between farnesoid-X- receptor { FXR} and peroxisome proliferator- activated receptor / contributes to the antifibrotic activity ofFXR ligands in rodent models of liver cirrhosis [ J ]. JPET, 2005, 315(1) = 58-68.
  • 7Yoshida K, Matsuzaki K. Differential regulation of TGF- 13/ Smad signaling in hepatic stellate cells between acute and chronic liver injuries[J]. Front Physiol, 2012, 3: 53.
  • 8Rath T, Menendez KM, K(Jgler M, et al. TIMP -1/-2 and transient elastography allow non invasive diagnosis of cystic fibrosis associated liver disease[ J]. Dig Liver Dis, 2012, 44 (9} : 780 -787.
  • 9Lee J, Seok S, Yu P, et al. Genomic analysis of hepatic far- nesoid X receptor binding sites reveals altered binding in obe- sity and direct gene repression by farnesoid X receptor in mice[J]. Hepatology, 2012, 56(1) 108 -117.
  • 10Fiorucci S, Rizzo G, Antonelli E, et al. A farnesoid x receptor -small heterodimer partner regulatory cascade modulates tissue metalloproteinase inhibitor -1 and matrix metallopro- tease expression in hepatic stellate cells and promotes reso- lution of liver fibrosis[J]. J Pharmacol Exp Ther, 2005, 314 (2) 584 -595.

共引文献70

同被引文献16

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部